Leading Team Science in Regenerative Medicine

  • Alexey E. Alekseev, Ph.D.
    Alexey E. Alekseev, Ph.D.
    • Dr. Alekseev has a focus on cell machinery and matching up the electrical and mechanical functions of cardiac cells.
  • David (D Kent) K. Arrell, Ph.D.
    David (D Kent) K. Arrell, Ph.D.
    • Dr. Arrell has expertise in specialized tools to study and quantify proteins in heart tissue and stem cells.
  • Atta Behfar, M.D., Ph.D.
    Atta Behfar, M.D., Ph.D.
    • Dr. Behfar is a transplant cardiologist and stem cell biologist with focus on cardiovascular regeneration. He directs the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program.
  • Soulmaz Boroumand, Ph.D.
    Soulmaz Boroumand, Ph.D.
    • Dr. Boroumand specializes in process development to realize the production of new therapies in a Good Manufacturing Practice (GMP) facility for clinical application.
  • Katherine M. Caflisch
    Katherine M. Caflisch
    • Ms. Caflisch is a graduate student studying connections between the microbiome and cardiovascular disease.
  • Jilian L. Foxen, M.Ed.
    Jilian L. Foxen, M.Ed.
    • Ms. Foxen has expertise in organizational leadership and professional development, with a focus on ensuring the needs of the program are met and operations align with the program's strategic vision and overarching mission.
  • Marie E. Frenzke
    Marie E. Frenzke
    • Ms. Frenzke is assisting in the GMP manufacturing of cell-free therapies and devices for clinical trials.
  • Amanda K. Golden, M.L.S.
    Amanda K. Golden, M.L.S.
    • Ms. Golden is a research librarian focused on writing and disseminating the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program's scientific discoveries to a broad audience.
  • Matthew L. Hillestad, Ph.D.
    Matthew L. Hillestad, Ph.D.
    • Dr. Hillestad is a gene therapy expert focused on developing cardiac-targeted technologies to deliver novel regenerative therapies to the heart.
  • Ryounghoon Jeon, Ph.D.
    Ryounghoon Jeon, Ph.D.
    • Dr. Jeon is evaluating stem cell behavior through careful preparation of highly purified and specialized cells.
  • Amrit Kanwar
    Amrit Kanwar
    • Ms. Kanwar is a medical student working on models of heart failure.
  • Mark Li
    Mark Li
    • Mr. Li is a M.D.-Ph.D. student focused on developing technologies for use in engineering new heart tissue.
  • Christopher Livia
    Christopher Livia
    • Mr. Livia is a M.D.-Ph.D. student. His research has yielded molecular vehicle technologies to protect the heart during heart attack and preserve organs for transplant.
  • Dhivya V (Dhivya Vadhana) Meenakshi Siddharthan, Ph.D.
    Dhivya V (Dhivya Vadhana) Meenakshi Siddharthan, Ph.D.
    • Dr. Meenakshi Siddharthan is identifying new therapeutic targets at the gene and protein levels using samples from patients.
  • Sungjo Park, Ph.D.
    Sungjo Park, Ph.D.
    • Dr. Park is an expert in protein structure and mechanics. He is utilizing nanoimaging tools to inform the design of biologics-based regenerative therapies.
  • Lois A. Rowe
    Lois A. Rowe
    • Ms. Rowe has expertise in processing tissue samples from research studies, allowing researchers in the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program to evaluate heart muscle tissue for signs of regeneration.
  • Paul G. Stalboerger, M.S., PMP
    Paul G. Stalboerger, M.S., PMP
    • Mr. Stalboerger is a project specialist facilitating research projects through the discovery-translation-application pipeline to ensure optimal use of available resources.
  • Ramandeep S. Takhter, Ph.D.
    Ramandeep S. Takhter, Ph.D.
    • Dr. Takhter is a cell biology expert developing novel tools that rapidly deliver curative genes (m3RNA) to heart tissue during heart attack to restore muscle function.
  • Andre Terzic, M.D., Ph.D.
    Andre Terzic, M.D., Ph.D.
    • Dr. Terzic is the director of the Center for Regenerative Medicine at Mayo Clinic.
  • Henry J. Walker
    Henry J. Walker
    • Mr. Walker is a specialist in GMP manufacturing. He leads the Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program's efforts to scale up and manufacture cell-free therapies and devices for clinical trials.
  • Tyra A. Witt
    Tyra A. Witt
    • Ms. Witt is developing avenues in surgical supportive care and investigative models to support the program's mission.
  • Satsuki Yamada M.D., Ph.D.
    Satsuki Yamada M.D., Ph.D.
    • Dr. Yamada is a cardiologist with expertise in translational models and cardiac imaging.